General Manager Conjugation Business

Danaher Corporation•Waltham, MA

23h•Hybrid

About The Position

Are you ready to accelerate your potential and make a real difference within life sciences, diagnostics and biotechnology? At Abcam, one of Danaher’s 15+ operating companies, our work saves lives—and we’re all united by a shared commitment to innovate for tangible impact. You’ll thrive in a culture of belonging where you and your unique viewpoint matter. And by harnessing Danaher’s system of continuous improvement, you help turn ideas into impact – innovating at the speed of life. Progress happens together At Abcam, we believe the scientific community goes further, faster when we go there together. That’s why we work with life scientists to provide biological reagents and solutions that enable faster breakthroughs in critical areas like cancer, neurological disorders, infectious diseases and metabolic disorders. Our talented team of over 1,400 colleagues worldwide is our greatest asset. By applying our expertise and pushing boundaries, together we strive to better serve our customers, strengthen our impact across our industry, and ultimately our positive impact on society. Learn about the Danaher Business System which makes everything possible. The General Manager, Conjugation Business is responsible for leading Abcam’s flow cytometry and conjugation growth agenda, including taking overall accountability for the delivery of the RUO Flow Reagent GCV, a breakthrough, cross-operating-company program critical to Danaher’s future growth. They will own the end‑to‑end business and product strategy for conjugation at Abcam and, together with Beckman Coulter Life Sciences (BECLS), create and manage a portfolio of products serving the research‑use‑only flow cytometry market. This role combines enterprise-level innovation leadership with business ownership, operating at the intersection of strategy, technology, customer value, and execution. The role offers the opportunity to lead a global, cross-operating-company, multi‑site project, with activities at Abcam’s Cambridge (UK) and Hangzhou (China) sites, and frequent interaction with BECLS teams in Miami (US) and Bangalore (India). This position can be located in the UK or the US, and the candidate will need a high level of flexibility to travel.

Requirements

A PhD, or equivalent, in a life sciences discipline
Long‑standing experience (10+ years) in RUO research reagents
Several years (5+ years) of experience managing people and leading teams
Deep expertise in flow cytometry, antibodies, dyes, and conjugation technologies
Strong product, portfolio, and business knowledge, with the ability to balance scientific depth with commercial decision‑making
Ability to distill complex scientific and technical topics and communicate effectively to both scientific and non‑scientific stakeholders
Proven ability to operate effectively in matrixed, global environments
Track record of delivering complex, cross‑functional programs on time and within agreed targets

Nice To Haves

Leading complex global, cross‑functional, or multi‑opco initiatives
Product management, portfolio ownership, or general management roles

Responsibilities

Own full P&L‑style accountability for the Conjugation business, driving sustainable revenue growth, portfolio performance, and customer value across flow cytometry and other applications.
Lead end‑to‑end program and product success, making critical trade-offs and investment decisions that balance customer value, revenue growth, quality, on‑time delivery, and product cost.
Shape the future through strategic product leadership by anticipating market and technology trends, defining long‑term portfolio strategy, and driving value creation through disciplined execution.
Partner closely with R&D, Operations, Finance, and Commercial teams to translate strategy into roadmap execution, ensuring clarity of ownership and decision‑making.
Elevate risk management and portfolio governance by pressure‑testing assumptions, enabling structured trade‑off discussions, and ensuring data‑driven decisions.
Lead with purpose by developing future product and business leaders, role-modeling DBS, Kaizen, and Danaher culture.
Business leader for Abcam’s Conjugation “Virtual Business Unit”, driving growth and operational excellence across Abcam’s conjugate portfolio.